Company intelligence / Profile preview

Bluepharma

Coimbra, Portugal

Ownership: Private
Employees: ~400
Development stage: Other

Overview

Bluepharma is commercial with a broad generics business and has platforms for innovative formulation technologies, including for advanced therapeutics (e.g., oncology). The company offers end-to-end pharmaceutical R&D, production, and CDMO services. Products are registered and sold in over 30 countries, including the US and EU, and internal R&D includes biopharma programs and oncology.

Modalities: Small moleculePeptidesNucleic acidPolymeric nanoparticlesLipid nanoparticle delivery therapy
Industry: Biotech

Partnerships

BayerTevaIvaxArrowEG LABO (Stada)Bexal (Hexal)Mepha (Ratiopharm)Ciclum (Grünenthal)ONConcept® (oncology collaboration in Europe)

Beyond the preview

Go deeper on Bluepharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bluepharma.

Explore the full profile